参考文献/References:
[1]Slice G, Stulpinas R, Poskus T, et al. Perivascular epithelioid cell tumor(PEComa) of the sigmoid colon: Case report and literature review.Curr Oncol,2025,32(6):330.
[2]Bonetti F, Pea M, Martignoni G, et al. PEC and sugar. Am J Surg Pathol,1992,16(3):307.
[3]Yan S, Lu JJ, Chen L, et al. Hepatic perivascular epithelioid cell tumors:the importance of preoperative diagnosis.World J Gastroenterol,2024,30(13):1926-1933.
[4]Zhou Y, Chen F,Jiang W,et al. Hepatic epithelioid angiomyolipoma with an unusual pathologic appearance: expanding the morphologic spectrum. Int J Clin Exp Pathol,2014,7(9):6364-6369.
[5]Ameurtesse H, Chbani L, Bennani A, et al. Primary perivascular epithelioid cell tumor of the liver: new case report and literature review. Diagn Patho,2014,9(1):149.
[6]Tang D, Wang J, Tian Y, et al. Hepatic perivascular epithelioid cell tumor: case report and brief literature review. Medicine,2016,95(51):e5572.
[7]Yang X, Li A, Wu M. Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases. Med Oncol,2013,30(1):416.
[8]史素素,万璐,娄纪刚,等.肝血管周上皮样细胞瘤临床及CT表现:与肝癌及肝腺瘤对比.中国医学影像技术,2025,41(6):938-942.
[9]Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol,2010,41(1):1-15.
[10]林德新,常贵建,卓信斌,等.基于Laennec膜理论的规范化腹腔镜肝段切除术的研究进展.中国普通外科杂志,2024,33(7):1153-1161.
[11]Hanzawa S, Monden K, Hioki M, et al. HowIdoit: Laparoscopic left medial sectionectomy utilizing a cranial approach to the middle hepatic vein and Laennec’s capsule. Langenbecks Arch Surg,2021,406(6):2091-2097.
[12]Karamarkovi A, Doklesti K. Preresectional inflow vascular control: extrafascial dissection of Glissonean pedicle in liver resections. Hepatobiliary Surg Nutr,2014,3(5):227.
[13]Dalle I, Sciot R, de Vos R, et al. Malignant angiomyolipoma of the liver: A hitherto unreported variant. Histopathology,2000,36(5):443-450.
[14]Guo B, He K, Hang H, et al. Peripheral subtractive dissection of glissonean pedicles in minimally invasive anatomic liver resection for right posterior lobe tumors. J Vis Exp,2025,7(217):e67514.
[15]Wagner AJ, MalinowskaKolodziej I, Morgan JA, et al. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol,2010,28(5):835-840.
[16]Bergamo F, Maruzzo M, Basso U, et al. Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa). World J Surg Oncol,2014,12:46.